McKesson Corporation (BMV:MCK)

Lumos Pharma Ratios and Metrics

Market cap in millions MXN. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,562,679	1,723,886	1,169,027	879,604	913,776	634,515
Market Cap Growth	24.92%	47.46%	32.90%	-3.74%	44.01%	13.22%
Enterprise Value	1,723,855	1,908,633	1,268,933	984,492	1,029,986	790,446
Last Close Price	12405.66	11969.10	8818.29	6159.56	6019.24	3732.80
PE Ratio	26.19	25.60	23.50	13.70	41.17	-
PS Ratio	0.22	0.24	0.23	0.18	0.17	0.13
PB Ratio	-96.02	-49.79	-44.12	-32.72	-25.59	21.47
P/FCF Ratio	13.80	15.20	18.17	10.22	11.33	7.59
P/OCF Ratio	12.66	13.86	16.35	9.45	10.34	6.84
EV/Sales Ratio	0.24	0.26	0.25	0.20	0.20	0.16
EV/EBITDA Ratio	15.39	17.24	14.99	11.32	10.79	9.80
EV/EBIT Ratio	18.53	19.00	16.74	12.65	12.46	12.18
EV/FCF Ratio	15.22	16.83	19.72	11.44	12.78	9.45
Debt / Equity Ratio	-11.52	-4.38	-4.64	-4.91	-4.25	6.61
Debt / EBITDA Ratio	1.67	1.25	1.32	1.37	1.42	2.11
Debt / FCF Ratio	1.66	1.34	1.91	1.53	1.88	2.34
Asset Turnover	4.94	5.04	4.76	4.41	4.11	3.77
Inventory Turnover	14.40	15.69	14.52	13.78	13.22	12.58
Quick Ratio	0.48	0.51	0.50	0.50	0.46	0.58
Current Ratio	0.88	0.90	0.92	0.92	0.95	1.03
Return on Equity (ROE)	-	-	-	-	-	-106.39%
Return on Assets (ROA)	4.03%	4.31%	4.41%	4.29%	4.04%	3.14%
Return on Capital (ROIC)	40.70%	53.21%	49.08%	46.31%	30.81%	14.63%
Return on Capital Employed (ROCE)	29.00%	36.30%	30.30%	30.00%	28.00%	15.20%
Earnings Yield	3.82%	3.91%	4.25%	7.30%	2.43%	-14.62%
FCF Yield	7.25%	6.58%	5.50%	9.78%	8.82%	13.18%
Dividend Yield	0.43%	0.47%	0.45%	0.61%	0.61%	0.91%
Payout Ratio	11.16%	10.47%	10.46%	8.20%	24.87%	-
Buyback Yield / Dilution	4.39%	4.47%	5.70%	7.72%	4.05%	11.56%
Total Shareholder Return	4.82%	4.94%	6.15%	8.33%	4.65%	12.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.